We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis—Reply

Kerstin Hellwig, MD1; Annette M. Langer-Gould, MD, PhD2
[+] Author Affiliations
1Department of Neurology, St Josef Hospital, Bochum, Germany
2Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena
JAMA Neurol. 2016;73(4):480-481. doi:10.1001/jamaneurol.2015.4821.
Text Size: A A A
Published online


In Reply Choudhary and Vinny raised the question about whether a difference in disease-modifying therapies (DMTs) among the women exclusively breastfed compared with those who did not breastfeed exclusively could have introduced bias to the results.1 We thank them for asking this question.

In the original article, there was indeed 1 inconsistency in Table 1: More women who chose not to breastfeed exclusively were treated with DMTs prior to (instead of during) pregnancy (84.2% of the exclusively breastfed group compared with 96.3% of the group that did not exclusively breastfeed; P = .007). Disease-modifying therapies were stopped with the recognition of pregnancy during the first trimester (more commonly in women who chose not to breastfeed exclusively; 36.7% vs 72.8% in the exclusive and nonexclusive breastfeeding groups, respectively; P < .001). It is plausible that the use of DMTs before pregnancy or becoming pregnant while taking DMT was not associated with postpartum relapse risk, as DMTs do not cure multiple sclerosis and their effect would not be expected to last 40 weeks. The large group of women treated with DMTs prior to pregnancy in our study1 might explain that the number of relapses in the 2 years before (in our case mostly while taking DMTs) pregnancy was not significantly associated with postpartum relapses compared with the PRIMS Study,2 as the natural disease activity was masked by the use of DMTs.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





April 1, 2016
Aditya Choudhary, MD; Wilson Pulikottil Vinny, MD
1Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
JAMA Neurol. 2016;73(4):480. doi:10.1001/jamaneurol.2015.4818.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...